An open-label pilot study to determine the efficacy of lopinavir/ritonavir and tenofovir DF in the treatment of HIV-infected patients experiencing first virologic failure on a non-nucleoside-based regimen

AIDS Patient Care STDS. 2008 Apr;22(4):263-6. doi: 10.1089/apc.2007.0148.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / administration & dosage
  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Adult
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / therapeutic use*
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1 / drug effects
  • Humans
  • Lopinavir
  • Middle Aged
  • Organophosphonates / administration & dosage
  • Organophosphonates / therapeutic use*
  • Pilot Projects
  • Pyrimidinones / administration & dosage
  • Pyrimidinones / therapeutic use*
  • RNA, Viral / blood
  • Reverse Transcriptase Inhibitors / administration & dosage
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Ritonavir / administration & dosage
  • Ritonavir / therapeutic use*
  • Tenofovir
  • Treatment Outcome

Substances

  • Anti-HIV Agents
  • Organophosphonates
  • Pyrimidinones
  • RNA, Viral
  • Reverse Transcriptase Inhibitors
  • Lopinavir
  • Tenofovir
  • Adenine
  • Ritonavir